HIV Resurgence Looms as Funding Cuts and Repressive Laws Undermine Global AIDS Response
Health

HIV Resurgence Looms as Funding Cuts and Repressive Laws Undermine Global AIDS Response

UNAids warns of a major threat to decades of progress as aid spending collapses, HIV testing plummets, and restrictive laws silence community health organizations worldwide.

By Mick Smith5 min read

Global HIV Progress Threatened by Funding Crisis and Human Rights Rollbacks

Decades of hard-won progress in the fight against HIV and AIDS now face their most serious threat, according to the United Nations agency leading the global response. A deepening funding crisis, combined with increasingly repressive legislation targeting civil society, is significantly raising the risk of a resurgence in HIV infections and AIDS-related deaths.

Winnie Byanyima, Executive Director of UNAids, described the current situation as "the biggest disruption since the global HIV response was put together," warning that it poses "a major threat to the progress we have had."

Record Lows Could Soon Be Reversed

A newly released UN report paints a stark picture of the road ahead. While annual HIV infections and AIDS-related deaths currently sit at historic lows — with 1.2 million new infections and 570,000 deaths recorded last year — these gains are increasingly fragile. Without a renewed and coordinated global commitment, experts warn that these numbers could begin climbing again in the near future.

The trigger for this alarming outlook is an unprecedented 23% decline in international aid spending, which has already begun rippling through health systems in the countries most affected by HIV.

HIV Testing Collapses in High-Burden Countries

One of the most immediate consequences of the funding cuts has been a sharp drop in HIV testing. In 2025, testing rates fell dramatically in nations with the highest rates of infection. Within a single program, tests conducted dropped by 22% compared to the previous year.

"That's huge," Byanyima said. "This means that people don't know that they are HIV positive, continue transmitting the virus, and so the disease will continue to spread and new infections will rise."

Delayed diagnosis also means delayed treatment — a dangerous gap that could prove fatal. "Maybe even more people will die because they don't show for treatment early enough or they don't get on treatment early enough," she added.

Prevention Services Hit Hardest

Beyond testing, prevention services have taken a particularly severe blow. Programs distributing condoms and providing pre-exposure prophylaxis — medication that protects against HIV infection — have been gutted by the aid cuts.

These services were already chronically underfunded, receiving just 11% of total HIV spending in low- and middle-income countries in 2024. Byanyima noted that even this modest allocation is now disappearing entirely.

New domestic funding from affected governments has not come close to filling the gap, and what funding does exist tends to prioritize treatment over prevention. Byanyima warned that the consequences will be measurable and severe: "rising new infections, and rising numbers of people dying of HIV-related illness" in the years ahead.

Repressive Laws Silencing Community-Led Health Organizations

Financial pressures are only part of the crisis. Byanyima also pointed to a growing wave of restrictive legislation that is shutting down the community-based organizations most effective at reaching vulnerable populations.

As an example, she cited Uganda's so-called "sovereignty bill," which limits external funding for civil society groups and curtails their ability to operate. Similar measures in other countries are eroding the grassroots networks that have historically served those at highest risk.

The impact has been devastating. A survey of 79 community-led organizations operating across 47 countries revealed an 85% reduction in services for men who have sex with men, and an 82% reduction in services for sex workers — two populations that bear a disproportionate burden of HIV risk. The report concluded bluntly that these organizations "are disappearing."

A Glimmer of Hope: New Prevention Technology

Despite the grim outlook, Byanyima acknowledged that meaningful opportunities exist. Chief among them is lenacapavir, a groundbreaking injectable HIV prevention drug administered just twice a year. She described it as a "miracle" development in the fight against the virus.

However, she emphasized that such innovations must be deployed at a far greater scale to "bend the curve" on new infections — something that becomes increasingly difficult without adequate funding and operational infrastructure.

UNAids Itself Faces an Uncertain Future

Ironically, UNAids is not immune to the very crisis it is sounding the alarm about. The agency has been directly impacted by funding cuts driven by the Trump administration's withdrawal of international aid commitments. The UN Secretary General has even proposed that UNAids be wound down entirely by the close of 2025.

Byanyima confirmed that a working group will present restructuring proposals to the UNAids board in October. She envisions the agency continuing in a reduced form — "a much smaller joint programme that is more dispersed within the UN but that continues to have a hub — leading for the UN and for the world."

The question of whether that hub will have the resources and reach to prevent a new HIV epidemic remains urgently and disturbingly open.